Post-effective amendment to a registration statement that is not immediately effective upon filing

Convertible Debt - Related Party (Detail Textuals 1)

v3.19.3.a.u2
Convertible Debt - Related Party (Detail Textuals 1)
1 Months Ended 9 Months Ended 12 Months Ended
Jan. 19, 2019
$ / shares
shares
Jan. 19, 2018
$ / shares
shares
Dec. 28, 2017
USD ($)
Day
$ / shares
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Short-term Debt [Line Items]              
Aggregate gross proceeds           $ 900,000  
Proceeds from secured convertible promissory note - related party         $ 400,000 400,000 $ 500,000
Funding of remaining bridge loan       $ 9,301     154,092
Convertible debt             $ 235,000
Loss on extinguishment of secured convertible promissory note - related party         $ (590,392) $ (590,392)  
Emerald Health Sciences Inc              
Short-term Debt [Line Items]              
Initial conversion price | $ / shares   $ 0.10          
Number of notes converted into common stock | shares   9,000,000          
Effective interest rate         13.94% 13.94% 13.94%
Emerald Health Sciences Inc | Subsequent Event              
Short-term Debt [Line Items]              
Initial conversion price | $ / shares $ 0.10            
Number of notes converted into common stock | shares 9,000,000            
Bridge Loan | Secured promissory note and security agreement | Emerald Health Sciences Inc              
Short-term Debt [Line Items]              
Aggregate gross proceeds     $ 900,000        
Bridge loan interest rate     12.00%        
Initial conversion price | $ / shares   $ 0.10 $ 0.10        
Proceeds from secured convertible promissory note - related party     $ 500,000        
Funding of remaining bridge loan     400,000        
Convertible debt     265,000        
Additional conversion liability     $ 360,000        
Number of trading days as of financing close date | Day     1